文献速递心力衰竭与心肌病

Ferumoxytol增强磁共振成像在急性心肌炎中的应用

Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis.
PubMed 文献 · Heart · 2017-10-06

研究纳入10名志愿者和14例疑似急性心肌炎患者,在基线及3个月时行3T MRI(T2、T2*、LGE),并在输注铁氧体磁微粒(ferumoxytol,4 mg/kg)后24小时复查T2*成像。结果显示,心肌炎患者LGE区域心肌水肿较健康志愿者心肌更显著,但USPIO增强在患者与志愿者之间无差异;3个月后患者LGE体积、水肿指标及射血分数均有改善。结论认为USPIO增强MRI未提供超越LGE和T2 mapping的额外临床相关信息。

要点

  • 急性心肌炎患者LGE区域T2值较健康志愿者心肌升高(57.1±5.3 vs 46.7±1.6 ms,p<0.0001)。
  • USPIO增强在患者与志愿者之间无差异,即使LGE区域亦无差异(R2*变化35.0±15.0 vs 37.2±9.6 s-1,p>0.05)。
  • 3个月随访显示LGE体积缩小、LGE区域水肿减轻、射血分数改善。

核心结论

  • 在急性心肌炎患者中,USPIO增强MRI未提供超越LGE和T2 mapping的额外临床相关信息,提示组织驻留巨噬细胞对该病心肌炎症贡献不大。

研究设计与样本

  • 前瞻性研究纳入10名志愿者和14例疑似急性心肌炎患者,行3T MRI(T2、T2*、LGE),并在ferumoxytol(4 mg/kg)输注后24小时复查T2*,基线及3个月随访。

主要发现

  • 14例疑似心肌炎中9例确诊心肌炎。
  • 心肌炎患者LGE区域心肌水肿较健康志愿者心肌更显著(T2值57.1±5.3 vs 46.7±1.6 ms,p<0.0001)。
  • USPIO增强在患者与志愿者之间无差异,即使LGE区域亦无差异(R2*变化35.0±15.0 vs 37.2±9.6 s-1,p>0.05)。
  • 3个月随访显示心肌炎患者LGE体积缩小(平均-19.7 mL,95%CI -0.5至-40.0)、LGE区域水肿减轻(-5.8 ms,95%CI -0.9至-10.7)及射血分数改善(+6%,95%CI 0.5%至11.5%),p均<0.05。

临床怎么用

  • 对于疑似急性心肌炎,USPIO增强MRI不推荐作为常规附加检查,LGE和T2 mapping已可提供诊断和随访所需信息。

局限性

  • 样本量较小(10名志愿者和14例疑似患者),可能影响统计效能和结果外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI can detect tissue-resident macrophage activity and identify cellular inflammation within tissues. We hypothesised that USPIO-enhanced MRI would provide a non-invasive imaging technique that would improve the diagnosis and management of patients with acute myocarditis. METHODS: Ten volunteers and 14 patients with suspected acute myocarditis underwent T2, T2* and late gadolinium enhancement (LGE) 3T MRI, with further T2* imaging at 24 hours after USPIO (ferumoxytol, 4 mg/kg) infusion, at baseline and 3 months. Myocardial oedema and USPIO enhancement were determined within areas of LGE as well as throughout the myocardium. RESULTS: Myocarditis was confirmed in nine of the 14 suspected cases of myocarditis. There was greater myocardial oedema in regions of LGE in patients with myocarditis when compared with healthy volunteer myocardium (T2 value, 57.1±5.3 vs 46.7±1.6 ms, p<0.0001). There was no demonstrable difference in USPIO enhancement between patients and volunteers even within regions displaying LGE (change in R2*, 35.0±15.0 vs 37.2±9.6 s-1, p>0.05). Imaging after 3 months in patients with myocarditis revealed a reduction in volume of LGE, a reduction in oedema measures within regions displaying LGE and improvement in ejection fraction (mean -19.7 mL, 95% CI (-0.5 to -40.0)), -5.8 ms (-0.9 to -10.7) and +6% (0.5% to 11.5%), respectively, p<0.05 for all). CONCLUSION: In patients with acute myocarditis, USPIO-enhanced MRI does not provide additional clinically relevant information to LGE and T2 mapping MRI. This suggests that tissue-resident macrophages do not provide a substantial contribution to the myocardial inflammation in this condition.Clinical trial registration NCT02319278; Results.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Stirrat CG, Alam SR, MacGillivray TJ, et al. Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis. Heart. 2017. PMID: 28986407. doi:10.1136/heartjnl-2017-311688

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。